|
|
4851 LBJ Freeway
Suite 400
Dallas
TX
75244
United States
214-630-2000
|
|
Private
|
InSightec developed ExAblate® 2000– a product that integrates Magnetic Resonance Imaging (MRI) with focused ultrasound energy -- as a new treatment modality that can replace invasive procedures and provide therapeutic alternatives to millions of patients with serious diseases around the globe.
ExAblate was approved by the U.S. Food and Drug Administration (FDA) in October 2004 to treat symptomatic uterine fibroids and to date over 3000 women have been treated worldwide for symptomatic uterine fibroids. InSightec has begun clinical trials to study the technology’s use in other indications including breast, bone, liver and brain tumors.
|
|
http://www.insightec.com
|
|
|
|
|
|
|
|
|
|
|
|